Skip to content
HowShorted

AnaptysBio, Inc. short interest in 2022

In 2022, AnaptysBio, Inc.'s disclosed short interest ran from 8.07% of shares outstanding on 14 Jan 2022 to 18.94% on 30 Dec 2022, a change of +10.87 percentage points. The year's high was 19.92% on 31 Oct 2022 and its low 8.07% on 14 Jan 2022, averaging 14.35% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 36.13 days on 31 Oct 2022. Full history: AnaptysBio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for AnaptysBio, Inc. in 2022

2022 in figures

Start of year
8.07% (14 Jan 2022)
End of year
18.94% (30 Dec 2022)
Change
+10.87 pp
High
19.92% (31 Oct 2022)
Low
8.07% (14 Jan 2022)
Average
14.35%
Highest days to cover
36.13 (31 Oct 2022)
SEC filings marked
8

Every report in 2022

AnaptysBio, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20228.07%14.00
31 Jan 20228.29%11.96
15 Feb 20228.49%15.43
28 Feb 20229.23%18.68
15 Mar 202210.09%14.8110-K filed, results (8-K)
31 Mar 20228.82%8.94
14 Apr 20228.56%12.84
29 Apr 202210.43%8.97
13 May 202213.22%6.5210-Q filed, results (8-K)
31 May 202211.95%10.89
15 Jun 202213.55%9.85
30 Jun 202214.02%12.75
15 Jul 202214.49%21.69
29 Jul 202216.23%19.33
15 Aug 202215.57%15.0310-Q filed, results (8-K)
31 Aug 202218.35%17.29
15 Sep 202219.16%14.59
30 Sep 202219.74%22.69
14 Oct 202219.45%34.23
31 Oct 202219.92%36.13
15 Nov 202219.48%25.5410-Q filed, results (8-K)
30 Nov 202219.06%26.08
15 Dec 202219.21%30.42
30 Dec 202218.94%27.16

See also: AnaptysBio, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.